Dr. Kuefler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1329 N Beaver St
Ste 1
Flagstaff, AZ 86001Phone+1 928-773-2260Fax+1 928-773-2402
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 1984 - 1986
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1976 - 1979
- Keck School of Medicine of the University of Southern CaliforniaClass of 1976
Certifications & Licensure
- AZ State Medical License 2021 - 2026
- OR State Medical License 1977 - 2025
- CO State Medical License 1980 - 2017
- MT State Medical License 1986 - 2008
- WY State Medical License 1987 - 1992
- NM State Medical License 1980 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACP) American College of Physicians, 2004
Publications & Presentations
PubMed
- 13 citationsResults of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.Nicholas J. Robert, Paul Conkling, Mark Allen O'Rourke, Paul R. Kuefler, Kristi J. McIntyre
Breast Cancer Research and Treatment. 2011-02-01 - 42 citationsGemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative studyDonald A. Richards, Paul R. Kuefler, Carlos Becerra, Lalan S. Wilfong, Robert H. Gersh
Investigational New Drugs. 2011-02-01 - 10 citationsResults of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.Thomas H. Cartwright, Paul R. Kuefler, Allen Lee Cohn, William J. Hyman, Maury Berger
Clinical Colorectal Cancer. 2008-11-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: